Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Oct;27(5):539-555.
doi: 10.1007/s12529-020-09891-8.

The Effects of Acceptance and Commitment Therapy (ACT) Intervention on Inflammation and Stress Biomarkers: a Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

The Effects of Acceptance and Commitment Therapy (ACT) Intervention on Inflammation and Stress Biomarkers: a Randomized Controlled Trial

Elina Järvelä-Reijonen et al. Int J Behav Med. 2020 Oct.

Abstract

Background: Psychological processes can be manifested in physiological health. We investigated whether acceptance and commitment therapy (ACT), targeted on psychological flexibility (PF), influences inflammation and stress biomarkers among working-age adults with psychological distress and overweight/obesity.

Method: Participants were randomized into three parallel groups: (1) ACT-based face-to-face (n = 65; six group sessions led by a psychologist), (2) ACT-based mobile (n = 73; one group session and mobile app), and (3) control (n = 66; only the measurements). Systemic inflammation and stress markers were analyzed at baseline, at 10 weeks after the baseline (post-intervention), and at 36 weeks after the baseline (follow-up). General PF and weight-related PF were measured with questionnaires (Acceptance and Action Questionnaire, Acceptance and Action Questionnaire for Weight-Related Difficulties).

Results: A group × time interaction (p = .012) was detected in the high-sensitivity C-reactive protein (hsCRP) level but not in other inflammation and stress biomarkers. hsCRP decreased significantly in the face-to-face group from week 0 to week 36, and at week 36, hsCRP was lower among the participants in the face-to-face group than in the mobile group (p = .035, post hoc test). Age and sex were stronger predictors of biomarker levels at follow-up than the post-intervention PF.

Conclusion: The results suggest that ACT delivered in group sessions may exert beneficial effects on low-grade systemic inflammation. More research is needed on how to best apply psychological interventions for the health of both mind and body among people with overweight/obesity and psychological distress.

Trial registration: ClinicalTrials.gov Identifier: NCT01738256, Registered 17 August, 2012.

Keywords: ACT; Low-grade inflammation; Mindfulness; Obesity; Psychological flexibility; Stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
The effects of ACT intervention on logarithmized hsCRP adjusted for study center and starting time of the study. The values are log-transformed estimated (adjusted for study center and starting time of the study) marginal means ± standard error (SE). The measurements were conducted before the intervention (baseline, study week 0), after the 8-week intervention period (study week 10), and 36 weeks after the baseline measurements (study week 36). The group × time interaction for the entire study period was significant (p = .012). The face-to-face and mobile groups had a significant difference at week 36 (p = .035, post hoc test, indicated with an asterisk). The decrease of hsCRP from week 0 to week 36 and from week 10 to week 36 was significant in the face-to-face group (p = .045 and p = .014, respectively)

References

    1. Antonelli M, Kushner I. It’s time to redefine inflammation. FASEB J. 2017;31(5):1787–1791. - PubMed
    1. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–867. - PubMed
    1. Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177–185. - PubMed
    1. Calder PC, Ahluwalia N, Albers R, Bosco N, Bourdet-Sicard R, Haller D, Holgate ST, Jönsson LS, Latulippe ME, Marcos A, Moreines J, M'Rini C, Müller M, Pawelec G, van Neerven RJJ, Watzl B, Zhao J. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br J Nutr. 2013;109(Suppl 1):S1–34. - PubMed
    1. Ahonen TM, Saltevo JT, Kautiainen HJ, Kumpusalo EA, Vanhala MJ. The association of adiponectin and low-grade inflammation with the course of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2012;22(3):285–291. - PubMed

Publication types

Associated data